American healthcare should be cheap and getting cheaper, easy to access, effective yet rapidly improving, and with nearly endless options for treatment, pricing, and method of delivery. The cheaper-faster-better dynamic we enjoy in high-tech areas that are not blighted by government regulation and control could and would apply to the medical and pharmaceutical industries if only we let it.